{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T07:10:50Z","timestamp":1707894650264},"reference-count":24,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.vaccine.2007.04.063","type":"journal-article","created":{"date-parts":[[2007,5,12]],"date-time":"2007-05-12T11:13:19Z","timestamp":1178968399000},"page":"5763-5770","source":"Crossref","is-referenced-by-count":7,"title":["Robust take following exposure to vaccinia virus: Case definition and guidelines of data collection, analysis, and presentation of immunization safety data"],"prefix":"10.1016","volume":"25","author":[{"given":"Philip L.","family":"Graham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip S.","family":"LaRussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin S.","family":"Kohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.04.063_bib1","unstructured":"World Health Organization. Declaration of global eradication of smallpox. Wkly Epidemiol Rec 1980;55:148."},{"key":"10.1016\/j.vaccine.2007.04.063_bib2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3201\/eid0504.990401","article-title":"About the first national symposium on medical and public health response to bioterrorism","volume":"5","author":"Henderson","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2007.04.063_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3201\/eid0504.990402","article-title":"Bioterrorism; how prepared are we?","volume":"5","author":"Shalala","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2007.04.063_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3201\/eid0504.990413","article-title":"Vaccines in civilian defense against bioterrorism","volume":"5","author":"Russel","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2007.04.063_bib5","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa013431","article-title":"Dose-related effects of smallpox vaccine","volume":"346","author":"Frey","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.04.063_bib6","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJMoa020534","article-title":"Clinical responses to undiluted and diluted smallpox vaccine","volume":"346","author":"Frey","year":"2002","journal-title":"N Eng J Med"},{"key":"10.1016\/j.vaccine.2007.04.063_bib7","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1001\/jama.289.24.3295","article-title":"Response to smallpox vaccine in persons immunized in the distant past","volume":"289","author":"Frey","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.04.063_bib8","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1016\/j.vaccine.2007.02.063","article-title":"The development of standardized case definitions and guidelines for adverse events following immunization","volume":"25","author":"Kohl","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.04.063_bib9","unstructured":"Centers for Disease Control and Prevention. Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR 2006;55(No. RR-1):1\u201316."},{"key":"10.1016\/j.vaccine.2007.04.063_bib10","unstructured":"CDC. Vaccinia (smallpox) vaccine recommendations of the advisory committee on immunization practices (ACIP), 2001. MMWR 2001;50(RR10);1\u201325. Report available on the world wide web: http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5010a1.htm [last accessed February 9, 2006]."},{"key":"10.1016\/j.vaccine.2007.04.063_bib11","unstructured":"CDC. Smallpox vaccination and adverse reactions. Guidance for clinicians. MMWR 2003;52(RR-4):1\u201328. Available on the world wide web: http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5204a1.htm [last accessed February 9, 2006]."},{"key":"10.1016\/j.vaccine.2007.04.063_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/375825","article-title":"Smallpox vaccination: a review, Part II, adverse events","volume":"37","author":"Fulginity","year":"2003","journal-title":"CID"},{"key":"10.1016\/j.vaccine.2007.04.063_bib13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jaci.2003.07.002","article-title":"Editorial: risks of smallpox vaccination: 200 years after Jenner","volume":"112","author":"Plaut","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2007.04.063_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2458-3-26","article-title":"Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963\u20131968","volume":"3","author":"Aragon","year":"2003","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2007.04.063_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/infdis\/122.4.303","article-title":"Complications of smallpox vaccination 1968 results of ten statewide surveys","volume":"122","author":"Lane","year":"1970","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2007.04.063_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJM196701192760301","article-title":"Complications of smallpox vaccination. Part I. National survey in the United States, 1963","volume":"276","author":"Neff","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.04.063_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00006454-199305000-00003","article-title":"Outbreak of pyogenic abscesses after diphtheria and tetanus toxoids and pertussis vaccination","volume":"12","author":"Simon","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2007.04.063_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1542\/peds.75.2.299","article-title":"Outbreaks of group A streptococcal abscesses following diphtheria\u2013tetanus toxoid\u2013pertussis vaccination","volume":"75","author":"Stetler","year":"1985","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2007.04.063_bib19","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1086\/425617","article-title":"Superinfection following smallpox vaccination (vaccinia), United States: Surveillance January 2003 through January 2004","volume":"39","author":"Vellozzi","year":"2004","journal-title":"CID"},{"key":"10.1016\/j.vaccine.2007.04.063_bib20","unstructured":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH). Guidelines for clinical safety assessment (E2a-e). Available on the worldwide web: http:\/\/www.ich.org\/ [last accessed February 9, 2006]."},{"key":"10.1016\/j.vaccine.2007.04.063_bib21","unstructured":"Council for International Organizations of Medical Sciences (CIOMS). Reporting form for international reporting of adverse drug reactions. Available on the worldwide web: http:\/\/www.cioms.ch\/frame-what-is-cioms.htm [last accessed February 9, 2006]."},{"key":"10.1016\/j.vaccine.2007.04.063_bib22","doi-asserted-by":"crossref","unstructured":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285(15):1987\u201391. Available on the worldwide web: http:\/\/www.consort-statement.org\/Statement\/revisedstatement.htm [last accessed February 9, 2006].","DOI":"10.1001\/jama.285.15.1987"},{"key":"10.1016\/j.vaccine.2007.04.063_bib23","unstructured":"Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet. 1999 Nov 27;354(9193):1896\u2013900. Available on the worldwide web: http:\/\/www.consort-statement.org\/Initiatives\/complements.htm [last accessed February 9, 2006]."},{"key":"10.1016\/j.vaccine.2007.04.063_bib24","doi-asserted-by":"crossref","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283(15):2008\u201312. Available on the worldwide web: http:\/\/www.consort-statement.org\/Initiatives\/complements.htm [last accessed February 9, 2006].","DOI":"10.1001\/jama.283.15.2008"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0700504X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0700504X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T06:47:11Z","timestamp":1707893231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0700504X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":24,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0264410X0700504X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.04.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}